IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells.
about
Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol dietsArginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectivesRole of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferationArginase and pulmonary diseasesGlucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophagesAgmatine induced NO dependent rat mesenteric artery relaxation and its impairment in salt-sensitive hypertension.Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosisBone marrow cell derived arginase I is the major source of allergen-induced lung arginase but is not required for airway hyperresponsiveness, remodeling and lung inflammatory responses in mice.Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomasChronic oral administration of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) improves erectile function in aged rats.Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model.Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation.Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide.Roles of arginase variants, atopy, and ozone in childhood asthma.Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties.Oxidized low-density lipoprotein inhibits nitric oxide-mediated coronary arteriolar dilation by up-regulating endothelial arginase IIntranasal peptide-induced tolerance and linked suppression: consequences of complement deficiencyArginase in retinopathy.Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox.Recent advances in arginine metabolism: roles and regulation of the arginases.Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells.From inflammation to wound healing: using a simple model to understand the functional versatility of murine macrophages.Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis.Arginase: marker, effector, or candidate gene for asthma?Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway.Expression profiles in surgically-induced carotid stenosis: a combined transcriptomic and proteomic investigationMolecular mechanisms of induction of antigen-specific allograft tolerance by intranasal peptide administration.Identification of 9 uterine genes that are regulated during mouse pregnancy and exhibit abnormal levels in the cyclooxygenase-1 knockout mouse.Arginase: a critical regulator of nitric oxide synthesis and vascular function.Pharmacologic agents elevating cAMP prevent arginase II expression and proliferation of pulmonary artery smooth muscle cells.Therapeutic benefits of phosphodiesterase 4B inhibition after traumatic brain injury.Arginine metabolism in vascular biology and disease.Regulation of avoidant behaviors and pain by the anti-inflammatory tyrosine phosphatase SHP-1.IL-13 receptor α2-arginase 2 pathway mediates IL-13-induced pulmonary hypertension.Role of arginase in vessel wall remodeling.Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation.Arginase and vascular aging.Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.Arginase promotes neointima formation in rat injured carotid arteriesInterleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma.
P2860
Q23909545-EAEEE02F-7B5F-46D0-8C05-BACAE3C5EC1AQ24650052-D30E0183-8A45-4F5C-8655-2673ED561B00Q28205767-5EF4F7B4-A211-4AC6-AA08-E598BBB484B5Q28385094-7785D609-4A06-44B0-ABB8-4F64CBEDA2F6Q28566905-5E56A849-9AF1-4B62-BB59-B24851A2606AQ30558172-57B7826E-8132-49B9-8437-CC81681C3756Q33429032-966C3FC2-0C06-49FE-9A06-8D002C957233Q33457721-B79C3BE0-25C7-4E96-B364-72875EF31137Q33522240-592FCEBD-17FF-4FAC-A4E8-2F6E26A06923Q33642371-407445C6-1B90-4854-ACF3-07018BC30DD7Q33716587-A2CD5722-43AE-4AFB-A987-79075F619C17Q33930612-F93403DC-A8B1-4D38-8EA2-5814D4F3C34CQ33948118-30A5F321-57E3-4CDE-A6D4-A6B80A34ACB6Q34034365-6F93666A-379B-4526-8992-62564BC33CCAQ34376402-6A4D255C-5F3A-4323-B550-966BE4658E38Q34679092-A8D1EF78-8889-4574-A134-DD1EC78585F2Q34691304-BDB35F2D-8566-4225-86AE-C2E3A101B841Q34800913-39F3A8A2-5351-4E14-8B19-806050AA7E13Q34961072-5321369A-0D0C-454E-B1E5-AEF57C2E715EQ34985733-70FFEB31-F503-45D0-B2BC-60AB9688447DQ35035933-5DA3E7EF-9EC2-4185-B3EA-5A0A93E4F884Q35091527-BAE26517-B0F5-4E62-8F48-C2A1FA9132FDQ35095605-8332D23A-6C29-4CE2-8DC0-3D1E7269525EQ35095621-6B111C29-83A2-4582-86D4-6ED4EFF5E11FQ35708220-3FE0586D-BA8E-4891-A596-0BDCC4786815Q35862479-86F6F80F-4A61-4169-80E8-4E7BC0C04B23Q35875231-9F79BCB4-256F-43CC-AA24-E0EB5FCCB9DDQ35928597-A9AE9F6F-D05A-49AA-8F09-D3C2DA297585Q35954810-8BC63C80-4556-4E53-B021-46EDBFD0AE0FQ36176946-9401A777-A8A7-4EDD-AD5B-D4AC64B800B0Q36380305-29D3E855-E11A-4B88-AC68-D3A700E039C9Q36381021-A7DB3E99-536B-4BCF-81DD-DFB957B7328BQ36426984-74C67602-D5A5-4CF3-96E6-064DD05F64D0Q36527952-BE062E40-DFA5-4BB0-8D00-7E8E0BD2B1DBQ36837617-2F71B06D-D21D-490B-9E66-C91F83E7848FQ36920831-EDDE5285-E537-4091-A233-8D9FD8B8D6A4Q36977086-3D8B4451-8697-475B-8724-6BE9A3A026BFQ37102697-21C1FFF0-9461-421F-9165-437D715EBB00Q37143923-A7CEE8E1-BD11-47DD-8405-64D9CB5BFC4FQ37239764-E744E173-BF1A-4814-8E71-45A5FE02FA60
P2860
IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
IL-4 and IL-13 upregulate argi ...... vascular smooth muscle cells.
@en
type
label
IL-4 and IL-13 upregulate argi ...... vascular smooth muscle cells.
@en
prefLabel
IL-4 and IL-13 upregulate argi ...... vascular smooth muscle cells.
@en
P2093
P2860
P1476
IL-4 and IL-13 upregulate argi ...... vascular smooth muscle cells.
@en
P2093
P2860
P304
P356
10.1152/AJPCELL.2000.279.1.C248
P577
2000-07-01T00:00:00Z